News & Media

Keeping our Media Partners in the Loop

23 September 2024

Pharmascience Canada launches a new medication for its patient

Read the article

9 September 2024

Pendopharm announces public drug coverage plan listings for Octasa® (oral mesalamine)

Read the article

9 July 2024

Pendopharm signs exclusive distribution agreement with Ascendis Pharma A/S for TransCon™ PTH in Canada

Read the article

16 May 2024

Pendopharm renews distribution agreement with Anika Therapeutics Inc. for Cingal®, Monovisc®, and Orthovisc®

Read the article

14 May 2024

Morris Goodman, Co-Founder and President Emeritus of Pharmascience Inc., Awarded Honorary Doctorate by INRS

Read the article

30 April 2024

Pharmascience Makes Great Place to Work’s Top 50 Best Workplaces in Canada!

Read the article

1 2 3 4 5 6 7 8 9 … 12

Media Relations

Please send us an email and provide us with your contact information as well as the name of your media/publication/source. A member of our team will contact you back quickly.

Topics

All Award/Recognition Business News Buying Locally COVID Employer Awards Our Divisions Product Launches Public Stance

About Pharmascience

Since 1983, Pharmascience has been a leading Canadian manufacturer of generic, branded, and over-the-counter pharmaceuticals, serving both domestic and international markets.

About Us

Professional Services Portal (Canada)

Healthcare Professional Authentication or Access? (Canada)

Keeping our Media Partners in the Loop

Pharmascience Canada launches a new medication for its patient

Pendopharm announces public drug coverage plan listings for Octasa® (oral mesalamine)

Pendopharm signs exclusive distribution agreement with Ascendis Pharma A/S for TransCon™ PTH in Canada

Pendopharm renews distribution agreement with Anika Therapeutics Inc. for Cingal®, Monovisc®, and Orthovisc®

Morris Goodman, Co-Founder and President Emeritus of Pharmascience Inc., Awarded Honorary Doctorate by INRS

Pharmascience Makes Great Place to Work’s Top 50 Best Workplaces in Canada!